NOVARTIS AG (MORE TO FOLLOW) Dow Jones Newswires
March 22, 2021 02:00 ET (06:00 GMT)
Novartis : appoints Karen Hale as Chief Legal Officer
March 22, 2021 at 11:30 am IST
Share
Share
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.22 CHF | +0.65% |
|
+1.03% | +9.90% |
| 16/05 | Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15 | DP |
| 16/05 | Novartis: presents results of tender offer for MorphoSysy | CF |
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:
- oncology (29.9%);
- immunology (17.2%);
- cardiovascular, renal and metabolic diseases (14.1%);
- neuroscience (8.9%).
The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.
At the end of 2023, Novartis AG had 33 production sites worldwide.
Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.4
USD
Average target price
108.5
USD
Spread / Average Target
+5.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.90% | 21TCr | |
| +32.30% | 69TCr | |
| +29.39% | 59TCr | |
| -1.57% | 37TCr | |
| +19.95% | 33TCr | |
| +6.63% | 29TCr | |
| +14.15% | 24TCr | |
| -3.03% | 21TCr | |
| +8.02% | 17TCr | |
| -0.84% | 16TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : appoints Karen Hale as Chief Legal Officer